Immune modulation by a cellular network of mesenchymal stem cells and breast cancer cell subsets: Implication for cancer therapy

Hussam S. Eltoukhy, Garima Sinha, Caitlyn A. Moore, Oleta A. Sandiford, Pranela Rameshwar

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

The immune modulatory properties of mesenchymal stem cells (MSCs) are mostly controlled by the particular microenvironment. Cancer stem cells (CSCs), which can initiate a clinical tumor, have been the subject of intense research. This review article discusses investigative studies of the roles of MSCs on cancer biology including on CSCs, and the potential as drug delivery to tumors. An understanding of how MSCs behave in the tumor microenvironment to facilitate the survival of tumor cells would be crucial to identify drug targets. More importantly, since CSCs survive for decades in dormancy for later resurgence, studies are presented to show how MSCs could be involved in maintaining dormancy. Although the mechanism by which CSCs survive is complex, this article focus on the cellular involvement of MSCs with regard to immune responses. We discuss the immunomodulatory mechanisms of MSC-CSC interaction in the context of therapeutic outcomes in oncology. We also discuss immunotherapy as a potential to circumventing this immune modulation.

Original languageEnglish (US)
Pages (from-to)33-41
Number of pages9
JournalCellular Immunology
Volume326
DOIs
StatePublished - Apr 2018

All Science Journal Classification (ASJC) codes

  • Immunology

Keywords

  • Cancer stem cell
  • Chimeric antigen receptor
  • Dormancy
  • Drug delivery
  • Immunosuppression
  • Mesenchymal stem cell

Fingerprint Dive into the research topics of 'Immune modulation by a cellular network of mesenchymal stem cells and breast cancer cell subsets: Implication for cancer therapy'. Together they form a unique fingerprint.

Cite this